» Articles » PMID: 38879493

AKI-Pro Score for Predicting Progression to Severe Acute Kidney Injury or Death in Patients with Early Acute Kidney Injury After Cardiac Surgery

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2024 Jun 15
PMID 38879493
Authors
Affiliations
Soon will be listed here.
Abstract

Background: No reliable clinical tools exist to predict acute kidney injury (AKI) progression. We aim to explore a scoring system for predicting the composite outcome of progression to severe AKI or death within seven days among early AKI patients after cardiac surgery.

Methods: In this study, we used two independent cohorts, and patients who experienced mild/moderate AKI within 48 h after cardiac surgery were enrolled. Eventually, 3188 patients from the MIMIC-IV database were used as the derivation cohort, while 499 patients from the Zhongshan cohort were used as external validation. The primary outcome was defined by the composite outcome of progression to severe AKI or death within seven days after enrollment. The variables identified by LASSO regression analysis were entered into logistic regression models and were used to construct the risk score.

Results: The composite outcome accounted for 3.7% (n = 119) and 7.6% (n = 38) of the derivation and validation cohorts, respectively. Six predictors were assembled into a risk score (AKI-Pro score), including female, baseline eGFR, aortic surgery, modified furosemide responsiveness index (mFRI), SOFA, and AKI stage. And we stratified the risk score into four groups: low, moderate, high, and very high risk. The risk score displayed satisfied predictive discrimination and calibration in the derivation and validation cohort. The AKI-Pro score discriminated the composite outcome better than CRATE score, Cleveland score, AKICS score, Simplified renal index, and SRI risk score (all P < 0.05).

Conclusions: The AKI-Pro score is a new clinical tool that could assist clinicians to identify early AKI patients at high risk for AKI progression or death.

Citing Articles

Development and validation of a prediction model for acute kidney injury following cardiac valve surgery.

Jia X, Ma J, Qi Z, Zhang D, Gao J Front Med (Lausanne). 2025; 12:1528147.

PMID: 39958823 PMC: 11825392. DOI: 10.3389/fmed.2025.1528147.

References
1.
Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw S, Bell M . Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013; 17(1):R25. PMC: 4057242. DOI: 10.1186/cc12503. View

2.
Koyner J, Garg A, Coca S, Sint K, Thiessen-Philbrook H, Patel U . Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol. 2012; 23(5):905-14. PMC: 3338298. DOI: 10.1681/ASN.2011090907. View

3.
Su Y, Zhang Y, Tu G, Hou J, Ma G, Hao G . Furosemide Responsiveness Predicts Acute Kidney Injury Progression After Cardiac Surgery. Ann Thorac Surg. 2023; 117(2):432-438. DOI: 10.1016/j.athoracsur.2023.07.011. View

4.
Nadim M, Forni L, Bihorac A, Hobson C, Koyner J, Shaw A . Cardiac and Vascular Surgery-Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. J Am Heart Assoc. 2018; 7(11). PMC: 6015369. DOI: 10.1161/JAHA.118.008834. View

5.
Liang W, Liang H, Ou L, Chen B, Chen A, Li C . Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020; 180(8):1081-1089. PMC: 7218676. DOI: 10.1001/jamainternmed.2020.2033. View